Monday, September 29, 2014: ACME Group and Schneider, two major players in the solar industry, are looking forward to foray into the Indian pharma industry by grabbing clear energy opportunities. The effort can result in reduction in carbon foot print, decline in diesel-run generators and also lead-acid batteries.
India is putting large efforts in battling power crisis to lessen the negative impact on manufacturing sector and solar seems to be the best solution. As pharma industry requires high quality power, solar being the source of renewable energy, can be used at a large in this industry to ensure that power deficit doesn’t impact the sector at all. Karnataka Electricity Regulatory Commission (KERC) exempted power generator companies from payment of wheeling or transmission charges. Subsidy charges for 10 years were also exempted. Solar is considered as the most suitable alternative to conventional power and it’s also the most useful source of power.
Pharma industries are asked to go solar to lessen dependence on grid power. As mentioned on Pharmabiz.com, Manoj Kumar Upadhyay, chairman & managing director, ACME Group, said, “Solar power is a cost-effective solution and is on par with the grid power cost but lower than the DG generated power cost. In the long run, solar power economics are better than any other conventional sources of power. With short construction time, modularity and simple operations and maintenance of solar power plant, it becomes a successful technology which will be the future of power generation.” Along with industrial parks and large solar plants, the government is initiating special incentives for customers too to encourage installation of solar plants.
